| AKT inhibitor VIII |
ENSG00000124835.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000126005.11 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000131484.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000132832.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000132832.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000145063.10 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000149656.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000152487.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000153363.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000153363.8 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000153363.8 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000157306.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000163597.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000170161.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000170161.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000170590.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000170590.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000170846.11 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000171889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000172250.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000172250.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000172965.10 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000172965.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000172965.10 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000173867.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000175147.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000175611.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000176840.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000177337.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000177738.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000177738.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000177757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000177757.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000177757.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000177822.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000177853.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000177993.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000178248.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000178412.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000178440.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000178440.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000178457.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000179219.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000179219.5 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000179447.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000179818.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000179935.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000180458.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000180712.3 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000180846.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000181097.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000181798.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000182109.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000182376.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000182586.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000182648.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000182648.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000183535.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000184068.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000184068.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000184068.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000184274.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000184274.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000185044.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000185186.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000185203.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000185904.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000185904.7 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000186056.5 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000186056.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000186148.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000186369.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000186594.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000186842.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000187156.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000187229.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000187621.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000187904.3 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000187979.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000188185.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000188338.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000188365.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000189223.9 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000189419.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000196273.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000196421.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000196421.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000196559.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000196668.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000196810.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000196951.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000196972.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000197210.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000197291.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000197291.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000197308.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000197332.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000197670.5 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000197813.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000198221.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000203321.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000203325.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000203325.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000203335.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000203362.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000203364.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000203441.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000203496.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000203496.4 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000203497.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000203506.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000203588.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000203709.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000203721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000203721.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000203729.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000203739.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000203849.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000203865.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000203865.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000203875.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000203875.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000203987.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000204044.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000204091.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000204091.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000204092.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000204110.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000204110.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000204241.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000204241.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000204362.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000204581.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000204623.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000204625.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000204625.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000204666.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000204706.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000204758.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000204792.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000204802.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000204802.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000204802.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000204837.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000204934.6 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000205054.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000205266.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000205424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000205500.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000205663.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000205663.5 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000205890.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000205959.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000205959.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000206028.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000206195.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000206195.6 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000212694.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000212694.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000212978.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000213468.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000213904.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000213963.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000213971.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000213994.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000213994.3 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000214353.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000214401.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000214432.5 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000214546.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000214650.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000214725.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000214770.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000214770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000214770.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000214783.5 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000214803.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000214851.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000214870.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000214894.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000214922.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000214922.5 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000214955.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000215023.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000215039.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000215068.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000215159.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000215241.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000215244.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000215246.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000215386.6 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000215394.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000215417.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000215417.6 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000215424.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000215458.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000215458.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000215841.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000215863.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000215863.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000215863.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000215866.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000215866.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000217576.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000218018.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000218018.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000219665.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000219665.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000219665.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000220925.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000221817.5 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000222041.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000222041.6 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000222043.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000223356.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223380.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223380.3 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000223382.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223387.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223387.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223396.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223401.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223401.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000223404.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223442.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000223477.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223478.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223478.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223478.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000223486.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223486.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223522.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000223522.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000223537.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223552.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223561.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223586.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000223660.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000223685.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223697.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223711.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223711.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000223725.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223745.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223745.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000223745.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000223759.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223768.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000223779.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223779.4 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000223791.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223791.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000223797.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000223804.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223804.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000223834.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223839.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000223839.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000223842.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223842.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000223855.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223855.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223882.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000223884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223884.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000223901.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223910.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223923.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223956.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000223960.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000223969.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223975.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000223979.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000224023.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224031.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224032.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224043.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224046.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000224049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224050.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000224057.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000224078.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224090.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224095.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000224128.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224165.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224167.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000224167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224189.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224243.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224251.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224271.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224276.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224292.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224292.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000224358.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224358.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000224358.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000224358.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000224394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224429.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224460.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000224505.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224505.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000224511.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000224533.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000224535.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224568.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224574.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224596.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224616.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224616.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000224616.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000224621.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000224635.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000224638.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000224660.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000224687.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224699.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224713.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224713.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224729.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224746.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224799.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224805.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224814.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000224817.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224846.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224855.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224855.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224875.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000224883.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224883.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224888.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224905.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000224914.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224934.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224939.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224961.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224961.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000224961.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000224969.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000225030.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000225032.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225037.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225037.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225037.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225037.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000225057.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225075.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000225111.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000225111.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225113.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225113.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000225146.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000225156.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225180.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225180.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225187.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225187.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000225205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225210.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225213.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000225218.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225218.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000225234.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225234.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000225269.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225278.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225278.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000225280.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000225331.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000225335.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000225376.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225411.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225417.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225439.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225439.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000225439.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225465.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225498.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225518.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225527.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225527.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000225528.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225532.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000225535.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000225541.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225559.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225632.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225643.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225675.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000225676.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225760.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000225760.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000225762.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225783.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225783.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000225791.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000225791.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000225792.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225798.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225806.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225850.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000225930.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225963.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225963.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000225969.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000225981.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226007.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000226009.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226009.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226026.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226029.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226067.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226067.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226067.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226070.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226070.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226087.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226091.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226113.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226125.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000226155.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000226200.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226203.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226235.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000226245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226245.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000226263.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000226287.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226291.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000226310.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000226328.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000226330.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226349.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000226352.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226381.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226383.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226383.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226434.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000226440.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226454.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226465.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226465.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000226471.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226471.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000226472.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226508.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226508.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226516.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000226520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226562.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226578.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226581.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226598.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226598.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226604.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226609.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226627.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226649.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000226676.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000226679.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000226696.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226699.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226717.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226746.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226746.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226747.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226752.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000226754.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226759.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226779.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226791.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226828.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226833.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226852.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226853.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000226862.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000226869.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000226872.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000226877.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226877.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000226889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226891.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226891.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226900.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226904.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000226913.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000226917.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000226917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000226950.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000226950.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000226954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000226957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227036.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227036.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000227039.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227045.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000227053.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227071.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000227107.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227165.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000227172.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000227200.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227214.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227218.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000227220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227245.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000227248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227279.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227285.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227352.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227354.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227354.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000227372.6 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000227375.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227388.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227438.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227456.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227456.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000227477.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227484.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000227484.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227487.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227487.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227492.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000227492.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000227496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227502.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000227502.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227512.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000227512.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000227518.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227540.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000227540.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000227542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227574.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000227591.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000227598.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000227603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227603.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000227627.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227627.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227627.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000227698.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227704.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227719.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227773.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227811.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227857.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000227895.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227896.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000227908.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227914.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000227946.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000227959.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000227959.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000228010.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000228010.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000228010.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000228013.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228016.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000228016.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228022.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000228037.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000228043.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000228063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000228108.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228109.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000228113.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228126.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228135.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228135.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228137.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000228137.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000228140.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228150.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000228153.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228201.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228214.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228223.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228242.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228251.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228251.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000228265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000228265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228274.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228274.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228288.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228294.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228302.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228318.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228322.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228327.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000228358.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228393.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000228404.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228414.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228423.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228423.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228436.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228437.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228444.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000228470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228481.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228485.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000228486.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000228487.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228487.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000228487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228506.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228544.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228544.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228577.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228577.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228604.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228604.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228629.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228629.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000228629.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228629.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000228630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228680.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228692.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000228697.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228701.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000228719.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228737.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000228742.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228748.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000228786.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000228791.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228801.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000228801.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000228802.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228802.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000228817.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228826.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228838.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000228839.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228852.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000228857.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228862.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228886.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000228889.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000228906.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000228939.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000228950.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000228989.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000229043.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000229044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229081.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000229122.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000229122.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000229124.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000229127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229140.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000229152.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000229154.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229162.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000229167.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229191.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229233.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229257.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229262.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229291.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229294.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229294.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229325.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229368.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000229373.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229401.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000229512.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229525.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229536.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229539.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000229558.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229558.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229569.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229582.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229587.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229587.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000229589.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229591.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000229618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229628.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229647.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000229656.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000229688.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000229692.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229694.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000229697.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229702.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000229727.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229727.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229739.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000229766.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229780.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000229801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229832.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000229839.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000229841.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000229841.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000229862.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229901.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229901.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229931.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229950.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229951.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229951.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229951.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000229952.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000229953.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000229953.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000229955.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229955.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000229956.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229956.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000229970.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229980.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229999.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000229999.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230010.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000230021.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230023.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000230061.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000230068.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230074.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230090.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230102.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000230109.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230113.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230124.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230124.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000230126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230174.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230177.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230269.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230300.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230303.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000230310.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230310.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000230314.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230316.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230333.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230337.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230366.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230366.5 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230410.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000230417.6 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230433.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230433.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230479.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230487.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230498.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230498.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230506.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230513.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000230523.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230530.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230550.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230552.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230555.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230555.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230555.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000230561.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230561.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000230565.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230565.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230606.6 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230612.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230612.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230615.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230648.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230649.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230679.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230724.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000230724.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000230729.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230732.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230732.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230735.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000230736.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230736.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230747.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230753.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230753.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000230798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230826.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230836.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230836.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000230850.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230850.3 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000230880.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230880.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230906.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230910.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000230912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230912.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000230922.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230925.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000230943.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000230978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231010.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000231024.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231024.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000231028.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000231054.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231064.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231079.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231079.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231083.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231119.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000231121.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231154.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231160.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231172.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000231185.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000231193.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000231212.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000231227.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231249.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231294.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231305.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231324.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000231327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231346.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000231367.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231393.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231429.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231437.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231439.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231460.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231460.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231473.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231473.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231485.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231507.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000231507.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231512.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231512.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231530.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000231533.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000231551.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231574.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000231595.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231595.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000231607.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000231609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231616.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231616.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000231636.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231636.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000231638.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231638.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231652.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231663.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000231690.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231734.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231764.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231769.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231789.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000231811.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231830.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231830.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231842.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000231856.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231856.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231856.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000231871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231890.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231920.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000231927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000231944.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000231966.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000231977.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000231999.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000231999.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000232018.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232019.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232021.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232031.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000232043.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000232044.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232044.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232046.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232065.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000232065.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000232065.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000232077.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000232079.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232116.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232116.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000232117.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000232118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232118.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000232124.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000232151.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000232160.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000232162.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232274.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232284.3 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000232300.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232300.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000232336.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232336.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000232342.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232352.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000232377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232386.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232396.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232415.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232442.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000232453.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000232453.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232455.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232470.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000232480.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232485.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232485.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000232527.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000232527.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000232533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232533.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000232542.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000232542.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000232545.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232586.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000232593.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232593.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232600.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232613.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232613.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232638.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232640.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232642.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232643.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232677.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232684.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232694.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232710.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232710.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000232710.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000232721.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000232725.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232725.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000232732.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232759.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232788.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232828.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000232874.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000232907.3 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000232909.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232909.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000232912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232934.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232934.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232934.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000232936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000232936.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000232936.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000232978.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000233008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233009.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233013.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000233016.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233016.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000233030.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233038.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233048.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000233048.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233056.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000233070.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233080.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233085.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000233086.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233108.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000233117.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233143.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233144.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000233154.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233178.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233203.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000233203.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000233208.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233230.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000233242.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233244.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000233246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233255.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233330.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000233330.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000233368.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233396.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233411.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000233427.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233427.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000233429.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233429.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000233429.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000233431.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233478.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000233509.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000233547.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233554.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233593.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233613.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000233613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233621.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233630.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000233635.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233644.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233644.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233661.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000233694.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000233718.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233757.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233775.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000233775.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000233783.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233785.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233797.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233797.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000233806.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233806.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233806.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000233817.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233821.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233825.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233834.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233862.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000233864.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000233885.3 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000233893.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000233895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233903.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233903.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000233906.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233912.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233912.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000233922.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000233926.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000233942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000233953.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234022.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000234026.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234028.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234062.3 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000234072.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234134.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234134.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000234160.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234185.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234185.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000234185.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234206.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234215.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234222.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234223.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234225.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234233.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234255.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234264.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234281.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234286.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234286.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000234290.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234336.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234350.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000234352.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234352.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234378.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234393.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234405.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000234428.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234449.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234456.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234456.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234478.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234492.4 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000234503.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234509.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234509.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000234520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234546.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000234601.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234608.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234608.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000234614.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000234616.4 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000234630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234630.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234650.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234678.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234678.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000234688.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234689.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234690.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234690.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234694.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000234694.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000234705.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000234705.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000234722.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000234740.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000234741.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234771.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234771.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000234779.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234789.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000234793.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234793.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000234807.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000234817.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234817.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000234840.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234899.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234912.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234913.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000234917.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234917.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000234917.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000234921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234936.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000234943.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234943.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234945.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000234978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000234978.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000234996.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235007.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235023.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000235024.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235024.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235052.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000235052.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000235072.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235078.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235085.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235092.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235092.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000235100.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235117.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235117.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235142.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235180.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235204.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235244.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235257.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235271.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235280.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235280.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235314.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235319.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000235373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235381.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235381.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000235385.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000235387.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235387.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000235398.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235398.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235408.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000235408.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000235426.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235427.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000235445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235453.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000235461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235475.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235477.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235481.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235481.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000235499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235522.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235523.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000235526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235529.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000235530.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235530.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000235545.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000235560.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235578.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235586.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000235586.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000235586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235590.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000235590.3 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000235593.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235609.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000235635.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000235641.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235643.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235652.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000235659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235688.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235703.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235706.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235760.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235760.3 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000235770.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235785.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235790.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235795.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235795.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000235795.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000235802.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000235806.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235806.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235823.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000235823.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000235831.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235852.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235872.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235903.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235908.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000235919.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235927.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235954.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000235999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236013.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000236021.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000236039.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236039.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236046.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000236051.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000236065.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000236066.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000236078.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000236091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236094.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236107.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236144.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236144.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000236188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236194.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236200.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000236244.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236255.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236266.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000236308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000236333.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236337.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000236364.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236364.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000236404.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236438.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236463.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000236467.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236498.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000236499.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236502.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236510.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236514.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236519.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236519.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236519.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000236519.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000236520.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236526.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000236528.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236545.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236545.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236558.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236558.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236581.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000236591.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236591.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236601.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000236643.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000236651.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236665.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236668.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236682.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000236703.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236711.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236717.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236780.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236799.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236824.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236830.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000236859.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236886.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236896.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000236901.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236901.3 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000236901.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236908.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236914.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236936.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000236943.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236943.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236953.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000236977.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000236986.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000236991.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000236991.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000237017.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000237021.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000237021.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000237036.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000237036.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237037.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237037.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000237054.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237094.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237094.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237094.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000237101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237125.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237125.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237126.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237187.4 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000237222.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000237253.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237281.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000237291.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237310.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237328.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000237336.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237357.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000237357.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000237407.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237416.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000237429.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237436.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237436.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000237457.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237463.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237471.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237481.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000237489.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000237499.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237512.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237520.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000237525.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237525.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000237594.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237685.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237718.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237718.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237738.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237738.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237742.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237750.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237753.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000237756.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000237773.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237781.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000237805.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237807.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237883.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237886.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000237886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237892.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237903.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000237928.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237934.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237937.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237938.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000237940.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237940.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237976.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000237976.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237978.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000237978.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000237980.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000237998.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000238005.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000238005.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000238009.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000238009.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000238035.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000238039.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000238042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000238058.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000238113.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000238121.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000238123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000238133.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000238141.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000238141.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000238186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000238186.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000238195.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000238197.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000238197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000238198.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000238250.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000238261.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000238273.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000238279.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000238279.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000238287.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000238290.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000239002.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000239213.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000239335.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000239335.4 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000239353.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000239353.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000239377.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000239415.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000239415.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000239446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000239462.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000239467.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000239480.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000239533.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000239552.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000239552.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000239636.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000239636.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000239774.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000239906.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000239906.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000239906.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000239911.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000239920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000239945.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000239945.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000240006.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000240015.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000240050.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000240063.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000240086.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000240093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000240143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000240198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000240207.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000240219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000240291.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000240350.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000240350.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000240401.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000240453.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000240497.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000240498.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000240499.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000240535.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000240541.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000240553.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000240553.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000240571.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000240618.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000240618.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000240710.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000240754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000240758.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000240758.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000240875.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000240990.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000240996.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000240996.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000241014.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000241054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000241101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000241155.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000241155.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000241163.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000241163.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000241163.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000241269.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000241280.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000241313.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000241316.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000241316.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000241316.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000241449.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000241475.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000241481.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000241505.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000241570.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000241593.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000241679.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000241684.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000241720.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000241720.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000241769.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000241769.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000241772.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000241818.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000241832.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000241860.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000241954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000241954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000241985.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000241985.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000242049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000242082.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000242086.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000242094.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000242094.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000242288.6 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000242396.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000242396.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000242474.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000242540.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000242553.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000242569.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000242578.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000242578.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000242593.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000242622.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000242641.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000242797.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000242861.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000242902.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000243083.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000243107.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000243187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000243224.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000243350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000243368.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000243389.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000243389.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000243415.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000243485.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000243797.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000243799.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000243810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000243836.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000243836.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000243926.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000243961.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000244124.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000244124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000244158.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000244184.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000244184.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000244198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000244215.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000244252.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000244306.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000244327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000244332.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000244393.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000244459.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000244513.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000244558.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000244564.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000244578.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000244586.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000244625.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000244675.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000244733.4 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000244757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000244879.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000244879.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000244945.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000244968.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000244968.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000245060.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000245112.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000245149.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000245213.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000245281.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000245281.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000245293.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000245311.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000245330.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000245479.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000245522.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000245532.4 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000245534.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000245571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000245648.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000245648.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000245685.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000245849.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000245857.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000245870.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000245904.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000245904.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000245910.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000245910.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000245975.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000246067.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000246090.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000246090.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000246130.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000246214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000246228.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000246250.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000246250.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000246263.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000246263.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000246323.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000246334.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000246339.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000246379.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000246379.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000246422.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000246451.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000246465.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000246465.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000246465.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000246523.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000246528.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000246528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000246560.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000246582.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000246627.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000246731.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000246763.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000246792.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000246820.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000246851.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000246851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000246863.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000246889.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000246898.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000246985.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000246985.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000247092.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000247095.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000247199.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000247199.3 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000247228.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000247271.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000247311.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000247363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000247363.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000247373.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000247373.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000247400.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000247416.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000247416.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000247498.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000247516.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000247595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000247624.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000247675.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000247708.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000247735.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000247765.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000247774.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000247934.3 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000247950.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000247982.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000248049.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248079.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000248092.3 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000248103.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248150.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000248174.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248175.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248187.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000248223.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248223.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000248240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248240.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000248243.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248254.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000248256.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000248265.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000248359.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000248367.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000248373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248429.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000248445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248461.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000248475.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248508.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000248516.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248554.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000248559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248559.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000248576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248587.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000248596.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000248668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000248671.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248693.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000248719.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000248733.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000248740.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248758.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000248773.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000248774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000248787.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000248846.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248858.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248866.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000248890.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248896.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248932.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000248932.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000248932.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000248936.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000248996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000249035.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249035.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000249131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000249241.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249249.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249249.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000249304.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249328.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000249348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000249352.3 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000249379.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000249395.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249417.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249417.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000249421.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000249464.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249464.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000249487.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000249500.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249502.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000249502.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000249509.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000249532.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000249592.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249593.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000249593.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000249595.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249602.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000249602.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000249604.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000249635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249635.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000249637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249637.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000249655.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000249685.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000249695.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000249740.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249786.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000249846.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249868.4 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000249894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249916.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000249981.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000249996.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000249996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250007.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250041.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000250046.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250049.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250061.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000250081.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250106.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000250107.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250129.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250129.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250155.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000250156.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000250159.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000250174.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250222.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000250234.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250260.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250260.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000250280.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000250295.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000250295.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250303.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250303.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000250320.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250326.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250337.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250362.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250362.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000250365.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250365.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250365.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000250366.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250387.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250397.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000250404.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250404.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000250415.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250432.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250432.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000250448.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250519.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250519.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250548.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250600.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000250602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250602.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250604.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250659.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000250698.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000250698.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250714.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000250740.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000250742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250764.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250765.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250786.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000250802.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250820.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000250820.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250893.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000250903.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000250909.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000250910.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250957.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250986.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000250988.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000251003.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000251003.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251009.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251010.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000251018.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000251022.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251022.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000251023.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000251072.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251075.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000251131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000251136.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000251136.4 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000251141.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000251141.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251144.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251148.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000251151.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000251168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251169.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251175.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000251179.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000251179.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000251194.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000251221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251221.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000251259.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000251298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000251307.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000251321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251323.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251359.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251361.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000251363.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000251396.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000251408.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251448.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000251461.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000251497.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000251497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251518.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000251532.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000251555.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000251556.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000251574.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000251580.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000251600.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251603.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000251604.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000251615.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000251615.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251623.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000251661.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000251666.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253106.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253130.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253134.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253161.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000253167.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000253187.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253196.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000253210.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253217.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000253227.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253227.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253230.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253301.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000253307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253317.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253317.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000253327.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000253335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253374.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253374.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000253385.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253390.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253392.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253395.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253414.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000253476.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253477.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253477.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253507.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253508.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253508.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000253513.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253513.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000253515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253535.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253549.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253557.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253562.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253584.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000253596.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253616.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253616.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253641.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253641.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253642.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253660.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253671.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253690.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253696.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253704.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253716.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253726.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000253737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253754.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253754.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253764.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253773.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000253829.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253829.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000253844.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000253848.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000253853.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253854.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253865.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253878.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253921.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000253925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253930.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000253948.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000253955.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253973.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000253978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000253978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254008.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254034.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000254042.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254057.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254109.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254141.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254144.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254154.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254202.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254204.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254205.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000254205.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254205.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000254208.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254224.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254231.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000254231.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000254248.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000254263.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254266.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254267.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254295.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254319.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254338.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000254341.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000254341.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000254363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254369.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000254370.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254389.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254389.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254418.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000254427.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254427.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000254428.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254432.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254468.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254485.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254510.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254538.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000254554.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000254557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254566.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254577.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000254592.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254610.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254615.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254620.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254635.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000254653.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254675.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254676.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254676.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000254682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254691.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254694.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000254777.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254791.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000254802.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254812.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254814.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254833.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254842.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254846.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254847.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254855.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254859.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254862.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000254865.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000254907.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000254910.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254934.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254936.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254967.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000254977.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000254987.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000254988.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000254990.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255020.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255027.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255031.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255031.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000255079.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255089.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255121.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000255121.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000255135.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000255139.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000255142.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000255164.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000255182.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255182.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000255186.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255197.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255198.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000255198.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000255216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255234.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000255236.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255236.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000255267.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255320.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000255326.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255326.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255328.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000255328.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255337.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000255343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255343.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000255355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255421.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000255428.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255434.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255434.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255446.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255449.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000255456.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255471.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255474.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255474.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255487.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000255495.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255503.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000255545.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000255557.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255559.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000255568.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000255568.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000255571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255669.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255717.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255717.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255843.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255847.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000255847.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000255856.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000255857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255933.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000255933.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255946.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255966.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000255970.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000255983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000255989.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000256006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000256084.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000256092.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000256115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000256128.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000256146.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000256150.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000256218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000256248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000256250.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000256278.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000256278.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000256278.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000256278.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000256299.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000256315.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000256360.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000256417.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000256443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000256458.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000256481.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000256542.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000256546.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000256546.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000256546.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000256705.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000256733.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000256747.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000256757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000256802.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000256802.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000256824.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000256824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000256894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000256943.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000256943.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000256967.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000256973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257004.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257027.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000257027.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000257056.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000257058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257058.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257139.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000257139.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000257151.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257191.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257191.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257202.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257222.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000257261.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000257261.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000257270.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257270.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000257272.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257279.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257283.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000257310.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000257322.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257337.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000257354.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000257381.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000257433.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257433.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257433.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000257438.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257449.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257467.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257475.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000257496.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257499.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257509.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000257509.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257534.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257534.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000257534.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000257543.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257556.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257568.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257613.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000257642.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257647.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257660.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257671.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257702.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000257702.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000257735.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000257808.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000257809.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257877.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000257964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258001.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000258007.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000258017.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000258044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258048.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258050.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258086.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258096.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000258099.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000258101.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258102.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258123.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258136.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258168.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000258168.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258169.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258181.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258260.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258301.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258323.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258325.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258334.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258337.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000258378.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000258400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258422.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258441.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258441.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258441.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258450.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258450.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258454.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258455.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258457.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258457.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258458.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000258479.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000258498.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258507.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258520.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258525.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258525.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258592.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258602.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258623.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258646.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258658.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258673.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258675.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258682.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258704.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258704.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000258704.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258711.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258730.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000258733.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000258748.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258754.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258798.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258808.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258811.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258821.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258857.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258858.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258891.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258891.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258926.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258940.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000258940.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000258949.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000258955.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258955.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258957.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000258957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258957.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000258959.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258959.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000258959.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259002.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000259017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259031.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259031.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000259055.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259062.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259062.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259083.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259084.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259116.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259129.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259129.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259138.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000259138.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259146.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259146.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259153.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259163.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259170.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259172.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000259172.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259182.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259187.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259206.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259206.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259209.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259218.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259235.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259241.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259254.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259277.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259294.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259298.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259310.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259314.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000259314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259336.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000259343.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000259354.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259360.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259364.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259366.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259370.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000259377.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259380.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259402.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000259416.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259418.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259422.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259426.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259426.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259448.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259453.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259462.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259483.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259488.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000259521.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000259523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259555.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259563.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259588.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259589.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259595.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259598.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259606.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259623.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259635.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259635.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259639.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259644.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259645.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259650.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259659.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259663.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259668.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259668.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259705.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259705.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259713.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259714.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259715.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259719.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259723.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259727.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000259736.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259736.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259758.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259760.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259762.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259762.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000259768.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000259771.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259772.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259772.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000259774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259774.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259782.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000259793.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259797.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259798.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259804.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259807.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259810.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259810.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259818.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259818.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259820.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259820.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259826.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000259828.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259834.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259840.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259863.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259877.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259899.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259953.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000259959.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000259969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259992.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000259994.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260017.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260018.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000260030.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260034.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260038.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000260060.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260063.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000260081.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260083.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260088.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260141.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000260145.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260162.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260163.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260179.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260196.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260196.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260197.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000260198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260206.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000260219.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260233.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260233.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000260248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260249.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000260257.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260260.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000260261.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260269.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260269.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000260269.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000260277.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260285.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260296.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260306.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260317.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000260329.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260331.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260336.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260337.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260349.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260351.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000260352.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260361.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000260361.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000260368.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260369.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260369.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260369.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000260372.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260388.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260396.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260398.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260398.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260400.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260400.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260400.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260400.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000260404.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260404.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260409.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260411.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260418.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260420.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260436.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260448.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000260455.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260464.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260464.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000260466.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260469.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260470.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000260493.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000260495.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260498.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260509.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260526.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000260528.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000260534.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260534.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000260555.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260572.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260572.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260572.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260572.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000260579.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260583.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260589.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260601.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260608.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260608.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260625.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000260630.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000260630.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260630.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000260637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260641.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000260643.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260645.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000260645.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260646.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260646.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260646.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000260647.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260664.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000260671.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260671.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260693.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000260708.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260743.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260743.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000260751.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260766.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260803.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260804.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260805.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260814.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000260814.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260831.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260831.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260833.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260838.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260841.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000260862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260871.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260884.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000260896.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260910.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260910.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260919.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260920.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000260923.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260923.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000260923.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000260924.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260924.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000260930.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260936.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260941.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000260942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000260948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260949.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260949.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000260973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000260989.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261000.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000261005.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261008.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000261015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261024.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261024.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261039.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261040.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261043.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000261051.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261064.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261069.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261087.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000261096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261096.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261098.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261123.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000261124.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261135.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261135.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000261140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261172.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000261173.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000261175.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261183.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261185.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261186.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000261187.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000261188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261189.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000261189.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261207.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261211.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261212.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261242.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261251.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261253.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261254.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261270.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261280.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261288.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261295.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261295.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000261326.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000261327.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261337.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261338.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000261341.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261353.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261355.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261357.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261366.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000261372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261373.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000261373.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000261374.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261396.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000261399.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261404.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261420.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261420.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000261425.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261428.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261428.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000261430.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261430.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000261431.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261435.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000261435.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261441.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261442.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000261447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261455.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261455.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261455.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261455.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261462.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261469.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261474.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261478.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261485.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000261496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261504.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261512.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261512.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261519.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261533.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000261543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261570.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261570.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261574.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261578.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261597.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000261597.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261597.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261600.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261613.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261632.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261644.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261655.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000261656.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000261662.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261662.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261663.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261663.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261692.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261697.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000261723.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261723.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000261730.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000261731.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261760.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261766.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000261766.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261770.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261789.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261797.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261804.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261823.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261823.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000261838.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000261838.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261840.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000261872.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261879.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261879.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000261886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261888.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261916.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261916.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000261971.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000261978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000261996.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000262001.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000262115.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000262119.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000262119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000262136.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000262136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000262152.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000262155.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000262188.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000262194.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000262202.3 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000262222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000262222.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000262313.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000262339.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000262372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000262410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000262410.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000262412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000262412.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000262454.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000262529.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000262580.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000262580.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000262619.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000262652.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000262652.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000262663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000262678.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000262678.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000262678.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000262681.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000262686.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000262703.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000262714.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000262745.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000262756.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000262766.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000262768.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000262772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000262777.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000262810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000262837.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000262881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000262903.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000262903.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000262921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000262944.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000262951.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000262952.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000262966.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000262973.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000263013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263050.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000263069.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000263072.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263080.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000263120.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000263120.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000263164.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263164.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000263214.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000263214.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000263244.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000263244.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000263244.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000263272.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263272.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000263307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263307.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000263331.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263338.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000263350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263388.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263393.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000263393.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000263393.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000263412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263466.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000263499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000263603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263627.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000263657.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000263680.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263680.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000263717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000263727.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000263766.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000263786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263843.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263874.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263874.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000263884.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000263893.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000263906.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000263906.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000263916.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000263924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000263924.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000263931.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000263938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000264007.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000264012.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000264043.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000264107.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000264112.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000264167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000264188.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000264196.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000264207.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000264235.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000264269.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000264301.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000264304.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000264304.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000264339.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000264339.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000264365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000264448.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000264458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000264469.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000264491.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000264491.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000264520.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000264548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000264569.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000264589.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000264647.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000264647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000264647.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000264673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000264745.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000264812.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000264860.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000264860.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000264860.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000264885.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000264885.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000264885.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000264895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000264920.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000264932.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000264940.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000265010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000265055.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000265055.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265185.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000265185.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265218.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000265242.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000265337.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265342.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000265394.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000265399.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000265443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000265445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000265474.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000265487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265496.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265511.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000265519.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000265547.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265625.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265625.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000265656.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000265666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265666.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000265692.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000265749.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265749.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000265791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000265791.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000265800.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000265801.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265845.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000265908.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000265912.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265962.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000265992.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000266010.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000266010.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266040.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000266079.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000266079.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000266100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266111.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000266120.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000266236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000266236.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000266236.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266256.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266278.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266304.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266312.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266313.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000266371.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000266401.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266456.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266469.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000266521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266538.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000266554.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000266599.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266651.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266654.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266709.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000266717.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266718.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000266821.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000266821.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000266824.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000266844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266903.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266904.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000266904.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000266912.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266916.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000266918.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000266921.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000266926.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000266933.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266934.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000266934.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000266935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000266936.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000266947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000266969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266969.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000266969.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000266970.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000266976.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000266993.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266993.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000266994.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000266999.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000267002.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267002.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267009.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267010.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000267010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000267010.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267011.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267018.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000267018.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267018.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000267024.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000267026.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267034.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267040.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267042.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267052.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267053.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267064.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267065.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267067.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000267080.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267082.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000267082.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267100.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267108.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267115.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267117.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000267117.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000267128.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267130.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267144.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267144.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267150.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000267151.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267152.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267159.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000267159.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000267161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000267183.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267194.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267194.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267198.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267201.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267212.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267214.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000267221.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267232.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267243.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267246.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267248.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267251.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267254.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267254.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267255.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000267255.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267268.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267278.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267279.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267288.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267311.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267313.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267347.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000267347.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267347.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267388.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267388.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267397.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267397.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000267414.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267419.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267432.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267432.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000267432.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267454.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267454.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267475.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267476.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267476.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000267479.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267479.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000267480.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267481.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267481.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000267505.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267510.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267510.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267530.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267530.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267543.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267546.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267546.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267547.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267547.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000267565.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000267568.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267581.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267581.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267586.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267612.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000267637.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000267638.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000267649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267649.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267651.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267651.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267651.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267655.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267658.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267666.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267682.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267690.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267701.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267701.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267705.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267705.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000267711.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000267730.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267745.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267745.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000267750.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267758.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267764.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000267764.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267765.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267778.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267778.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267783.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267786.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267787.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267804.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267834.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267868.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267868.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267898.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267939.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000267939.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000267940.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000267986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000268006.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000268006.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000268027.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000268047.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000268047.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000268051.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000268066.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000268081.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000268087.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000268093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000268095.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000268204.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000268205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000268307.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000268340.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000268355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000268362.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000268362.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000268364.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000268366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000268392.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000268458.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000268471.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000268496.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000268499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000268516.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000268518.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000268518.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000268568.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000268573.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000268584.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000268605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000268649.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000268654.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000268670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000268683.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000268746.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000268836.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000268889.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000268889.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000268912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000268912.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000268938.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000268945.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000268947.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000269019.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269038.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269038.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000269054.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269086.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269091.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000269091.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269102.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000269102.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000269107.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000269191.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000269194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269194.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000269194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269220.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000269246.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269290.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000269290.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000269293.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000269293.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000269321.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000269356.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269386.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000269399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269423.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269425.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269425.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000269427.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000269473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269481.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000269481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269487.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000269489.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269560.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269609.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269609.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000269640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269653.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269656.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269656.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269688.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269694.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269696.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269696.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269696.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000269752.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269793.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269814.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269825.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000269834.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269834.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000269836.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000269887.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000269893.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269901.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000269906.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000269908.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269911.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269923.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269923.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000269925.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269938.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269942.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000269942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269945.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269947.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000269949.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269951.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269951.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000269951.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269958.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269961.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000269961.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000269971.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000269978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269979.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269983.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000269989.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000269997.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000269997.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000269999.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000270006.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000270010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270010.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270012.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270018.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270018.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000270019.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000270019.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000270020.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000270028.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270028.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000270035.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270039.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000270039.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000270041.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270048.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270048.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000270049.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270049.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000270049.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000270061.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270062.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000270062.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270062.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000270066.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270083.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270090.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270095.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270100.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270102.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270104.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270108.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000270108.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000270109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270109.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000270110.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270115.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270116.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000270127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270130.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270140.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270141.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270154.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000270154.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000270157.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270165.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270171.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270173.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270178.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270189.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270195.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000270210.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270210.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270223.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000270246.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270265.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000270332.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270344.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000270346.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270361.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000270419.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270419.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270419.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000270457.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270482.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000270522.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270571.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000270580.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000270589.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270589.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000270604.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000270605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270605.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000270640.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000270673.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000270681.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270681.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270681.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000270704.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270720.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270828.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000270933.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000270949.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270949.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270951.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000270964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270988.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000270988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000270996.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000271032.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000271086.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000271109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271119.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271151.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000271185.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000271200.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271204.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000271234.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271259.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000271265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271270.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271314.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000271320.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271335.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000271344.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000271347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271382.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271387.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271398.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271420.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000271538.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271538.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000271551.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271551.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000271555.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000271590.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271590.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271659.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271659.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000271659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271727.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271734.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271738.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271743.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000271751.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000271757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271757.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000271761.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000271763.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271771.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271778.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000271788.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000271789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271816.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000271825.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271830.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271833.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271833.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271840.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000271845.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271849.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271851.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000271855.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271855.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000271855.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000271857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271857.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271857.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000271869.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271869.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271874.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271888.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000271889.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271912.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271912.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000271913.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000271914.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000271916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271926.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000271931.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000271938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271948.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000271948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271952.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271963.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271963.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000271964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271966.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000271967.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000271971.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271975.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000271978.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000271992.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000271993.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271996.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000271996.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000271997.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272003.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272005.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272005.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272010.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272024.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000272030.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000272033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272040.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272048.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272048.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272048.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272048.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272065.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000272068.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272068.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272072.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272076.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272076.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272076.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000272077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272077.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272079.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272079.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000272087.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272123.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272128.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000272129.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000272137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272142.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000272143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272143.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272144.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272146.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000272148.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272158.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272168.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272183.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000272205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272216.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272219.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000272221.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272225.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272240.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272255.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272288.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000272301.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272301.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000272301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272316.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272328.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272338.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000272338.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272343.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272365.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000272365.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272369.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000272372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272379.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272386.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272420.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272440.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272444.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272452.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272462.2 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000272463.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272463.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000272473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272505.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000272505.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272506.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272508.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272508.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272516.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272518.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272520.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000272524.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272524.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272529.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272556.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272556.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000272562.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272562.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272568.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272604.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272610.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000272630.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272631.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000272644.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272645.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272645.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272650.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000272659.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272662.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000272668.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272669.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272677.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272688.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000272691.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000272695.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272695.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272696.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272702.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000272707.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272716.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272719.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000272720.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272721.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000272721.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272732.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272734.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272745.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000272755.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272755.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272758.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272760.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272761.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272764.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272764.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272764.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000272769.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272769.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272782.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272782.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000272787.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272792.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272796.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000272798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272810.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272812.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272828.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000272828.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272829.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000272834.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000272836.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272839.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272846.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272848.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272848.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000272849.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272849.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272853.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272853.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000272855.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272858.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272858.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000272859.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272859.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000272862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272870.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272872.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272872.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272885.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272904.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272915.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272915.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000272927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272940.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272940.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272940.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272942.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000272949.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272950.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272953.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272954.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272966.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000272977.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272979.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000272983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272983.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000272992.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000272995.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000272995.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000273001.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273002.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000273002.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000273004.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273004.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000273007.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273008.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273008.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273009.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000273011.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273011.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273015.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273017.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273018.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273018.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000273019.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273026.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273027.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273058.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273061.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273066.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273066.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273075.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273076.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273084.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273096.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000273100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273108.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273113.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273148.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273162.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000273164.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000273165.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273174.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273176.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000273181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273181.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000273186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273193.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273203.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000273203.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273218.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273218.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273230.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273230.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273232.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273237.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273243.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273245.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000273245.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000273247.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273247.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273267.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273270.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273271.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273271.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273281.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000273290.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273295.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273297.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273305.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000273306.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273309.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000273319.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273319.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000273321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273325.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273335.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000273343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273343.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000273350.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000273352.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000273367.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273369.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273374.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273374.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000273381.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273402.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273402.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273416.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273424.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000273424.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273428.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000273432.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000273437.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273442.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000273443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273443.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273443.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000273445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000273449.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273451.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273456.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273456.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273456.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AKT inhibitor VIII |
ENSG00000273456.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273461.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AKT inhibitor VIII |
ENSG00000273472.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273474.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AKT inhibitor VIII |
ENSG00000273474.1 |
Predicted lncRNA |
Sarcoma |
|
| AKT inhibitor VIII |
ENSG00000273483.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273483.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273488.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AKT inhibitor VIII |
ENSG00000273488.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AKT inhibitor VIII |
ENSG00000273488.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AKT inhibitor VIII |
ENSG00000273493.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AKT inhibitor VIII |
ENSG00000273493.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|